<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02580136</url>
  </required_header>
  <id_info>
    <org_study_id>2015C0066</org_study_id>
    <nct_id>NCT02580136</nct_id>
  </id_info>
  <brief_title>Esthesioneuroblastoma: Outcomes After Treatment</brief_title>
  <acronym>ENB</acronym>
  <official_title>Esthesioneuroblastoma: Outcomes After Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ricardo L. Carrau, MD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ohio State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to collect and organize data into a repository to gather
      relevant information for future research from patients diagnosed with a rare malignant
      sinonasal cancer called esthesioneuroblastoma (ENB) and are scheduled to undergo endonasal
      skull base surgery. Data being collected includes surgical data, demographics, disease
      presentation, MRI, CT, PET imaging, and post-operative assessments including pathology tests.
      After surgery, the investigators will collect chemotherapy and radiation data. Participants
      will also complete quality of life questionnaires at their follow-up visits.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">September 2026</completion_date>
  <primary_completion_date type="Anticipated">September 2025</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>120 Months</target_duration>
  <primary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>up to 120 months after treatment</time_frame>
    <description>Anterior Skull Base (ASB); Skull Base Inventory (SBI); Multidimensional Disease Specific Inventory MDS; ASB-Nasal 12; Sino-Nasal Outcome Test (SNOT-20)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Progression-free survival and overall survival</measure>
    <time_frame>Up to 120 months</time_frame>
    <description>Kalpan-Meier survival curves</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of participants with intraoperative complications</measure>
    <time_frame>up to 120 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with postoperative complications</measure>
    <time_frame>up to 120 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Hospital Stay</measure>
    <time_frame>up to 120 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time spent in operating room</measure>
    <time_frame>up to 120 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MRI imaging evidence of resection</measure>
    <time_frame>up to 120 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical Technique</measure>
    <time_frame>up to 120 months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Esthesioneuroblastoma, Olfactory</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients diagnosed with esthesioneuroblastoma (ENB)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Between the age of 10-80 years

          -  Diagnosed with esthesioneuroblastoma

        Exclusion Criteria:

          -  Refusal to participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ricardo Carrau, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ohio State University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amanda McGill, MA</last_name>
    <phone>614-685-8622</phone>
    <email>amanda.mcgill@osumc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amanda McGill, MA</last_name>
      <phone>614-685-8622</phone>
      <email>Amanda.McGill@osumc.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2015</study_first_submitted>
  <study_first_submitted_qc>October 19, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 20, 2015</study_first_posted>
  <last_update_submitted>March 31, 2017</last_update_submitted>
  <last_update_submitted_qc>March 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Ohio State University</investigator_affiliation>
    <investigator_full_name>Ricardo L. Carrau, MD</investigator_full_name>
    <investigator_title>Ricardo L. Carrau, MD</investigator_title>
  </responsible_party>
  <keyword>Esthesioneuroblastoma</keyword>
  <keyword>Tumor</keyword>
  <keyword>Skull Base Surgery</keyword>
  <keyword>Sinonasal Cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Esthesioneuroblastoma, Olfactory</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

